Results 231 to 240 of about 131,241 (336)

Immunoexpressions of PD-L1 and EZH2 in Endometrial Carcinoma: Associations with Clinicopathological Parameters. [PDF]

Diagnostics (Basel)
Abdul Wahab BI, Shah SA, Mohd Arshad R, Alfian N, Tan GC, Wong YP.   +5 more
europepmc   +1 more source

Treatment for patients with stage-1 endometrial carcinoma [PDF]

, 2000
Carien L. Creutzberg, Wim van Putten
openalex   +1 more source

The Methylation Test Is Highly Sensitive for HPV‐Associated Endocervical Adenocarcinoma and Could Be Helpful as a Cytological Ancillary Test in Women With a PAP‐Smear Diagnosis of Severe Glandular Lesion (AGC–NEO+)

Cytopathology, EarlyView.
Based on an analysis of 85 endocervical adenocarcinoma (EA) cases with cytology–histology correlation, the authors document a methylation test sensitivity of 95.3% for diagnosing EA. If used as an ancillary test, the methylation test may improve the PAP test's reliability.
Iva Kinkorová Luňáčková, Ondrej Ondič, Jana Němcová, Kateřina Černá, Jan Chytra, Jiří Bouda   +5 more
wiley   +1 more source

Expression Analysis of FANCD2 in Endometrial Carcinoma. [PDF]

Cancer Manag Res
Zhang L, Chang J, Wu X.
europepmc   +1 more source

Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia

Histopathology, EarlyView.
Aims Peritoneal inclusion cysts (PICs) are mesothelial‐lined cysts that can uncommonly develop squamous metaplasia. Here, we describe the immunophenotype of PICs with squamous metaplasia using a comprehensive immunohistochemical (IHC) panel. Methods and results We collected surgical excisions of PICs with squamous metaplasia from our institution and ...
Heather I Chen‐Yost, David B Chapel, Steven M Hrycaj, William R Perry, Kristine E Konopka, Jeffrey L Myers, Tao Huang   +6 more
wiley   +1 more source

Impact of the microcystic, elongated, and fragmented invasion pattern on prognosis in endometrial carcinoma: a comprehensive meta-analysis. [PDF]

Front Oncol
Zhou L, Li C, Zhao J, Li P, Qu P.
europepmc   +1 more source

PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review

Immunology, EarlyView.
Myeloid cell PI3Kγ can be activated by G Protein‐Coupled Receptors or Receptor Tyrosine Kinases. Once activated, PI3Kγ promotes integrin activation as well as Akt and mTOR activation, thereby promoting transcription of immune‐suppressive and pro‐angiogenic factors, such as Arginase, IL‐10, TGFβ and VEGF‐A.
Anghesom Ghebremedhin, Judith A. Varner
wiley   +1 more source

Locally advanced port-site metastasis following laparoscopic surgery for early-stage endometrial carcinoma: a case report. [PDF]

J Surg Case Rep
Echiguer S, Elgraini S, El Bouazizi Y, Belkouchi FZ, Tijami F, Omor Y, Latib R, Hachi H, El Bahaoui N.   +8 more
europepmc   +1 more source

The Landscape of Cancer Metabolism as a Therapeutic Target

Pathology International, EarlyView.
ABSTRACT Cancer cells reprogram their metabolism during progression to adapt to the tumor microenvironment, which is characterized by distinct differences in nutrient availability, oxygen concentrations, and acidity. This metabolic reprogramming can simultaneously create metabolic vulnerabilities unique to cancer cells, making cancer metabolism a ...
Kenji Ohshima
wiley   +1 more source

ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma. [PDF]

Braz J Med Biol Res
Chaves CBP, Nicolau-Neto P, Simão TA, Souza-Santos PT, Bergmann A, Brewer L, Moreira FCB, Reis BSB, Moreira MAM, Pinto LFR.   +9 more
europepmc   +1 more source